1050447-11-4 Usage
Uses
Used in Pharmaceutical Applications:
(R)-1-benzoyl-3-(benzoylamino) piperidine is used as a chemical intermediate for the development of various pharmaceuticals, given its unique structure and potential biological activity. Its role in the synthesis of medications may contribute to the treatment of specific diseases or conditions.
Used in Scientific Research:
In the field of scientific research, (R)-1-benzoyl-3-(benzoylamino) piperidine serves as a valuable compound for studying its interactions with biological systems. This research can provide insights into the compound's potential applications in drug discovery and development, as well as its mechanisms of action.
Check Digit Verification of cas no
The CAS Registry Mumber 1050447-11-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,5,0,4,4 and 7 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1050447-11:
(9*1)+(8*0)+(7*5)+(6*0)+(5*4)+(4*4)+(3*7)+(2*1)+(1*1)=104
104 % 10 = 4
So 1050447-11-4 is a valid CAS Registry Number.
1050447-11-4Relevant academic research and scientific papers
METHOD FOR PRODUCING OPTICALLY ACTIVE 3-AMINOPIPERIDINE OR SALT THEREOF
-
Page/Page column 21, (2010/05/13)
The present invention relates to a method for producing an optically active 3-aminopiperidine or salt thereof. In the method, a racemic nipecotamide is stereoselectively hydrolyzed to obtain an optically active nipecotamide and an optically active nipecotic acid in the presence of an enzyme source derived from an organism, and then the optically active nipecotamide is derived into an optically active aminopiperidine or salt thereof by aroylation, Hofmann rearrangement, deprotection of the amino group and further deprotection; or the optically active nipecotamide is derived into an optically active aminopiperidine or salt thereof by selective protection with BOC, Hofmann rearrangement and further deprotection. It is possible by the present invention to produce an optically active 3-aminopiperidine or salt thereof useful as a pharmaceutical intermediate from an inexpensive and easily available starting material by easy method applicable to industrial manufacturing.
